Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)
Jordan · Delayed Price · Currency is JOD 3.260
0.00 (0.00%)
At close: Jun 7, 2026
ASE:HPIC Cash Flow Statement
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2.03 | 2.31 | 3.09 | 2.33 | 3.53 | 3.64 |
Depreciation & Amortization | 1.23 | 1.22 | 1.1 | 1.09 | 1.05 | 0.9 |
Other Amortization | 0.05 | 0.05 | 0.04 | 0.04 | 0.01 | - |
Loss (Gain) From Sale of Assets | 0.01 | 0.01 | -0.02 | - | - | - |
Provision & Write-off of Bad Debts | 0.38 | 0.38 | - | - | - | 0.13 |
Other Operating Activities | 0.28 | 0.22 | 0.2 | 0.25 | 0.03 | 0.16 |
Change in Accounts Receivable | 1.2 | -1.47 | -0.98 | -0.33 | -1.9 | 2.54 |
Change in Inventory | 0.69 | 0.84 | -0.09 | -0.19 | -0.41 | -0.5 |
Change in Accounts Payable | -0.36 | -0.19 | 0.14 | -0.36 | 0.45 | -1.38 |
Change in Other Net Operating Assets | -0.35 | 0.21 | -0.21 | -0.04 | 0.35 | 0.04 |
Operating Cash Flow | 5.14 | 3.58 | 3.28 | 2.78 | 3.11 | 5.53 |
Operating Cash Flow Growth | 32.31% | 9.05% | 17.99% | -10.59% | -43.80% | 44.72% |
Capital Expenditures | -1.29 | -0.41 | -1.69 | -0.34 | -0.87 | -1.59 |
Sale of Property, Plant & Equipment | - | 0 | 0.04 | - | - | - |
Sale (Purchase) of Intangibles | -0.05 | -0.08 | -0 | -0.09 | -0.19 | - |
Other Investing Activities | - | - | - | - | 0.19 | - |
Investing Cash Flow | -1.34 | -0.49 | -1.65 | -0.43 | -0.88 | -1.59 |
Short-Term Debt Issued | - | - | 0.05 | - | - | 0.54 |
Long-Term Debt Issued | - | - | 1.84 | 1.07 | - | - |
Total Debt Issued | 0.82 | - | 1.89 | 1.07 | - | 0.54 |
Short-Term Debt Repaid | - | -0.07 | - | -0.32 | -0.13 | - |
Long-Term Debt Repaid | - | -0.27 | - | - | -0.76 | -0.62 |
Total Debt Repaid | -0.24 | -0.35 | - | -0.32 | -0.89 | -0.62 |
Net Debt Issued (Repaid) | 0.58 | -0.35 | 1.89 | 0.75 | -0.89 | -0.09 |
Common Dividends Paid | -2.09 | -2.09 | -1.57 | -2.38 | -2.38 | -1.9 |
Other Financing Activities | -0.14 | -0.14 | -0.15 | -0.1 | -0.07 | -0.09 |
Financing Cash Flow | -1.65 | -2.58 | 0.17 | -1.73 | -3.33 | -2.08 |
Net Cash Flow | 2.16 | 0.52 | 1.79 | 0.62 | -1.1 | 1.87 |
Free Cash Flow | 3.86 | 3.17 | 1.59 | 2.44 | 2.23 | 3.95 |
Free Cash Flow Growth | 79.59% | 99.49% | -35.01% | 9.26% | -43.38% | 29.43% |
Free Cash Flow Margin | 23.63% | 18.50% | 9.50% | 15.45% | 13.07% | 23.80% |
Free Cash Flow Per Share | 0.41 | 0.33 | 0.17 | 0.26 | 0.23 | 0.42 |
Cash Interest Paid | 0.14 | 0.14 | 0.15 | 0.1 | 0.07 | 0.09 |
Cash Income Tax Paid | 0.36 | 0.48 | 0.48 | 0.51 | 0.64 | 0.63 |
Levered Free Cash Flow | 3.18 | 2.39 | 0.57 | 1.64 | 1.04 | 2.92 |
Unlevered Free Cash Flow | 3.26 | 2.47 | 0.67 | 1.7 | 1.08 | 2.98 |
Change in Working Capital | 1.17 | -0.61 | -1.14 | -0.92 | -1.52 | 0.7 |